Developer docs
API playgroundTry for free, no card

Search company profiles

Neurofinity

Full company profile

uuid02l7jza

Namestring
Neurofinity
Legal namestring
Neurofinity
Websiteurl
neurofinity.com
Company typeenum
Private
Founded yearint
2025
Descriptiontext

Neurofinity is a Sedona, Arizona-based private healthcare technology company founded in 2025 that delivers a technology-enabled, whole-person care model for opioid use disorder (OUD). The company embeds its offering inside existing care delivery organizations — health systems, outpatient clinics, and residential treatment centers — rather than marketing directly to consumers. Its core product is the Treus Recovery Intelligence Platform, an AI-assisted longitudinal recovery management system that combines continuous data integration across clinical, behavioral, and social determinants of health (SDOH) inputs with proprietary measurement frameworks (Psychosocial Vital Signs and Recovery Vital Indicators) and adaptive care plans spanning five recovery stages.

Treus is augmented by two human service layers: Amplified Peer Recovery Professionals (APRPs), who provide lived-experience peer support, and Super Navigators, professionally trained care coordinators who resolve root-cause SDOH barriers (housing, employment, transportation, criminal justice involvement) and ensure continuity across hospital, residential treatment, outpatient, sober living, home, and community recovery settings. Operational deployment is anchored by a flagship partnership with Morse Clinics in North Carolina and a co-development relationship with the University of Virginia health system.

Neurofinity generates revenue primarily through value-based reimbursement arrangements that align financial incentives with measurable recovery outcomes rather than episodic service volume. The company maintains an ecosystem of technology (GenieMD, Videra Health), SDOH (Upside Housing), peer staffing (Promise Resource Network), and policy/government relations (McGuireWoods Consulting, Tripp|Hollander Advisors) partners. The company is privately held, co-founded by Raphael Rakowski (CEO), Paula Calabrese (CPO), and Andy Lipman (CFO), with additional leadership including Rachel Blasko (COO) and Dr. Justin Yang (CMO), and has 1-10 employees.

Short descriptiontext

Neurofinity is a Sedona-based private healthcare technology company that embeds an AI-assisted OUD recovery platform (Treus) plus peer recovery and care navigation services inside health systems, clinics, and residential treatment centers, with value-based reimbursement tied to recovery outcomes.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSedona, United States
HQ citystring
Sedona
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
opioid use disorder recovery, behavioral health technology, peer recovery support, care coordination platform, value-based care delivery
Industry2 codes
PRIMARYHLALABAK
Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLALABAG
Post-Acute & Transitional Care Virtual Platforms (SNF/home health coordination)
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Behavioral Health Technology / Addiction Recovery Platform
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Value-Based Reimbursement
TypeUsage Based
Description

Neurofinity's primary revenue model is anchored in value-based reimbursement, where carefully measured patient recovery metrics are combined with economic impact data to create a mutually aligned value proposition for patients, providers, and payers. This approach aligns financial incentives with measurable recovery outcomes rather than episodic service volume.

neurofinity.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1Treus™ Recovery Intelligence
Description

AI-assisted Recovery Intelligence Platform purpose-built for opioid use disorder, combining longitudinal measurement, adaptive care planning, and coordinated care workflows to personalize recovery support over time.

neurofinity.com
Core offering1 text field

Neurofinity delivers a personalized, technology-enabled end-to-end OUD care model combining the AI-assisted Treus Recovery Intelligence Platform with Amplified Peer Recovery Professionals (APRPs) and Super Navigators. The platform provides longitudinal measurement, adaptive care planning, and coordinated workflows across hospitals, residential treatment centers, clinics, sober living, home, and community recovery settings. Provider partners receive qualified personnel, elevated training/credentialing, and the Treus technology infrastructure to deliver continuous, whole-person recovery support.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Overdose mortality is declining significantly — but the OUD disease burden remains enormous and substantially under-measured, with an annual economic burden of the opioid crisis exceeding $1 trillion.
+1 more record
Product overview1 text field

Neurofinity offers a unified platform-plus-services model for continuous opioid use disorder (OUD) recovery, built around the Treus Recovery Intelligence Platform as its core technology layer. The platform is complemented by two human-centered service offerings: Amplified Peer Recovery Professionals (APRPs), who provide peer-based emotional support and lived-experience connection, and Super Navigators, who coordinate care and resolve social determinants of health barriers. All three components are integrated and mutually reinforcing — the Treus platform supports and amplifies APRPs and Super Navigators, while the human services provide trust, accountability, and real-world context that enrich the platform's data and adaptive capabilities.

Product and service3 records
1Treus Recovery Intelligence Platform
CategorySoftware Platform
Description

An AI-assisted longitudinal recovery management system purpose-built for opioid use disorder, combining real-time measurement, adaptive care planning, and coordinated care workflows to personalize recovery support across all care settings over time. Features include Recovery Vital Indicators, Psychosocial Vital Signs, and an Outcomes Dashboard. Sold to healthcare provider organizations (health systems, clinics, residential treatment centers) as the technology backbone of Neurofinity's embeddable OUD care model.

2Amplified Peer Recovery Professionals (APRPs)
CategoryService Offering
Description

Uniquely trained and certified patient partners with lived opioid use disorder experience who provide emotional trust and authentic connection, working alongside patients, Super Navigators, and clinical teams, and supported by the Treus Recovery Intelligence Platform to deliver continuous 24/7 engagement throughout recovery. Delivered to healthcare provider organizations as embedded personnel within their care teams.

3Super Navigators
CategoryService Offering
Description

Professionally trained navigators who represent patients across the entire care continuum, collaborate with care providers, resolve root-cause social determinants of health challenges (housing, jobs, transportation, criminal justice), and ensure continuity and cohesion across multiple providers and therapies — supported by the Treus Recovery Intelligence Platform. Delivered to healthcare provider organizations as embedded personnel.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
1Morse Clinics
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Morse Clinics serves as a primary operating and launch partner for Neurofinity in North Carolina, representing the first deployment of the Neurofinity care model in a live clinical environment. This is a flagship partnership for market validation and model refinement.

neurofinity.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

University of Virginia operates as a health system partner, integrating the Neurofinity model within its existing care delivery infrastructure as part of a strategic co-development relationship focused on evidence-based OUD care transformation.

Strategic tierCoreTypeTechnology or Integration
Description

GenieMD provides OUD care technology platform capabilities as part of Neurofinity's broader technology ecosystem, contributing to the technology infrastructure supporting the Treus platform's care coordination and clinical enablement functions.

Strategic tierCoreTypeTechnology or Integration
Description

Videra Health provides AI behavioral health platform technology integrated into Neurofinity's ecosystem, supporting the AI-assisted measurement and monitoring capabilities of the Treus Recovery Intelligence Platform.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Upside Housing provides housing support services addressing social determinants of health for Neurofinity patients, integrated into the Super Navigator workflow to resolve housing instability — a key driver of relapse and barrier to recovery.

6Promise Resource Network
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Promise Resource Network provides peer staffing, training, and oversight services as part of Neurofinity's clinical and peer support ecosystem, contributing to the APRP credentialing and training program and ensuring quality peer recovery support delivery.

neurofinity.com
Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

McGuireWoods Consulting provides government relations and advocacy consulting to Neurofinity, supporting policy engagement and regulatory navigation related to OUD care reimbursement, funding, and policy reform.

8Tripp|Hollander Advisors
Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Tripp|Hollander Advisors provides government relations and advocacy consulting services to Neurofinity, supporting efforts to advance supportive policy and reimbursement frameworks for OUD care innovation.

neurofinity.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

AI behavioral health platform partner already integrated into Neurofinity's ecosystem. Comparable as an enabling technology provider supporting AI-assisted measurement and monitoring.

TypeDirect peer
Description

Outpatient addiction and mental health provider combining medication-assisted treatment, therapy, and peer recovery support with value-based payer contracts. Comparable integrated OUD/SUD care model with peer-led support.

TypeDirect peer
Description

Predecessor identity of Pelago; historically focused on digital addiction treatment. Listed for completeness as a directly overlapping digital SUD/OUD platform.

TypeDirect peer
Description

Telehealth-based provider of medication-assisted treatment and peer recovery support for opioid use disorder. Comparable as a digitally delivered, peer-supported OUD care model targeting payer partnerships and outcomes-based contracts.

TypeEmerging player
Description

Virtual intensive outpatient and mental health platform for adolescents and adults. Adjacent behavioral health virtual care with growing SUD focus; comparable on platform-enabled, longitudinal virtual care delivery.

TypeDirect peer
Description

Telehealth provider of substance use disorder treatment including opioid use disorder, delivered via group and individual counseling. Comparable digital OUD/SUD care delivery model.

TypeDirect peer
Description

Digital substance use disorder treatment platform serving payers, health systems, and employers with virtual care for tobacco, alcohol, and opioid use disorders. Directly comparable as a B2B-embedded digital SUD/OUD platform pursuing value-based contracts.

TypeBroad incumbent
Description

Large employer-focused mental health platform expanding into substance use care. Comparable as a broader digital behavioral health incumbent serving enterprises and payers.

TypeDirect peer
Description

Virtual substance use disorder care provider offering medication-assisted treatment and counseling for opioid and alcohol use disorders, with B2B partnerships to health plans and providers. Closely aligned on digital OUD treatment and value-based reimbursement.

10Ophelia
TypeDirect peer
Description

Telehealth platform providing medication-assisted treatment for opioid use disorder, working with health plans and Medicaid on value-based arrangements. Highly comparable on OUD focus, virtual delivery, and payer-aligned reimbursement.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Neurofinity

Behavioral Health Technology / Addiction Recovery Platformneurofinity.com

Neurofinity is a Sedona-based private healthcare technology company that embeds an AI-assisted OUD recovery platform (Treus) plus peer recovery and care navigation services inside health systems, clinics, and residential treatment centers, with value-based reimbursement tied to recovery outcomes.

What Neurofinity does

Neurofinity is a Sedona, Arizona-based private healthcare technology company founded in 2025 that delivers a technology-enabled, whole-person care model for opioid use disorder (OUD). The company embeds its offering inside existing care delivery organizations — health systems, outpatient clinics, and residential treatment centers — rather than marketing directly to consumers. Its core product is the Treus Recovery Intelligence Platform, an AI-assisted longitudinal recovery management system that combines continuous data integration across clinical, behavioral, and social determinants of health (SDOH) inputs with proprietary measurement frameworks (Psychosocial Vital Signs and Recovery Vital Indicators) and adaptive care plans spanning five recovery stages.

Treus is augmented by two human service layers: Amplified Peer Recovery Professionals (APRPs), who provide lived-experience peer support, and Super Navigators, professionally trained care coordinators who resolve root-cause SDOH barriers (housing, employment, transportation, criminal justice involvement) and ensure continuity across hospital, residential treatment, outpatient, sober living, home, and community recovery settings. Operational deployment is anchored by a flagship partnership with Morse Clinics in North Carolina and a co-development relationship with the University of Virginia health system.

Neurofinity generates revenue primarily through value-based reimbursement arrangements that align financial incentives with measurable recovery outcomes rather than episodic service volume. The company maintains an ecosystem of technology (GenieMD, Videra Health), SDOH (Upside Housing), peer staffing (Promise Resource Network), and policy/government relations (McGuireWoods Consulting, Tripp|Hollander Advisors) partners. The company is privately held, co-founded by Raphael Rakowski (CEO), Paula Calabrese (CPO), and Andy Lipman (CFO), with additional leadership including Rachel Blasko (COO) and Dr. Justin Yang (CMO), and has 1-10 employees.

Neurofinity firmographics

Firmographics
Name
Neurofinity
Legal name
Neurofinity
Website
https://neurofinity.com
Company type
Private
Founded year
2025
Operating status
Operating
Headcount range
1–10 employees
Short description
Neurofinity is a Sedona-based private healthcare technology company that embeds an AI-assisted OUD recovery platform (Treus) plus peer recovery and care navigation services inside health systems, clinics, and residential treatment centers, with value-based reimbursement tied to recovery outcomes.
Ownership category
akta.pro rank

Neurofinity industry classification

Industry
Product category
Behavioral Health Technology / Addiction Recovery Platform
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLALABAK
Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLALABAG
Post-Acute & Transitional Care Virtual Platforms (SNF/home health coordination)
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)

Keywords

  • Opioid use disorder recovery
  • Behavioral health technology
  • Peer recovery support
  • Care coordination platform
  • Value-based care delivery

Where Neurofinity is headquartered

Location

Headquarters

HQ city
Sedona
HQ country
United States
HQ region
North America

Markets served

Neurofinity business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

  1. Value-Based Reimbursement: Neurofinity's primary revenue model is anchored in value-based reimbursement, where carefully measured patient recovery metrics are combined with economic impact data to create a mutually aligned value proposition for patients, providers, and payers. This approach aligns financial incentives with measurable recovery outcomes rather than episodic service volume.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Neurofinity product offering

Product offering

Core offering

Neurofinity delivers a personalized, technology-enabled end-to-end OUD care model combining the AI-assisted Treus Recovery Intelligence Platform with Amplified Peer Recovery Professionals (APRPs) and Super Navigators. The platform provides longitudinal measurement, adaptive care planning, and coordinated workflows across hospitals, residential treatment centers, clinics, sober living, home, and community recovery settings. Provider partners receive qualified personnel, elevated training/credentialing, and the Treus technology infrastructure to deliver continuous, whole-person recovery support.

Product overview

Neurofinity offers a unified platform-plus-services model for continuous opioid use disorder (OUD) recovery, built around the Treus Recovery Intelligence Platform as its core technology layer. The platform is complemented by two human-centered service offerings: Amplified Peer Recovery Professionals (APRPs), who provide peer-based emotional support and lived-experience connection, and Super Navigators, who coordinate care and resolve social determinants of health barriers. All three components are integrated and mutually reinforcing — the Treus platform supports and amplifies APRPs and Super Navigators, while the human services provide trust, accountability, and real-world context that enrich the platform's data and adaptive capabilities.

Differentiator

Problem solved

Functional benefit

Brands

  • Treus™ Recovery Intelligence: AI-assisted Recovery Intelligence Platform purpose-built for opioid use disorder, combining longitudinal measurement, adaptive care planning, and coordinated care workflows to personalize recovery support over time.

Products and services

  • Treus Recovery Intelligence Platform An AI-assisted longitudinal recovery management system purpose-built for opioid use disorder, combining real-time measurement, adaptive care planning, and coordinated care workflows to personalize recovery support across all care settings over time. Features include Recovery Vital Indicators, Psychosocial Vital Signs, and an Outcomes Dashboard. Sold to healthcare provider organizations (health systems, clinics, residential treatment centers) as the technology backbone of Neurofinity's embeddable OUD care model.
  • Amplified Peer Recovery Professionals (APRPs) Uniquely trained and certified patient partners with lived opioid use disorder experience who provide emotional trust and authentic connection, working alongside patients, Super Navigators, and clinical teams, and supported by the Treus Recovery Intelligence Platform to deliver continuous 24/7 engagement throughout recovery. Delivered to healthcare provider organizations as embedded personnel within their care teams.
  • Super Navigators Professionally trained navigators who represent patients across the entire care continuum, collaborate with care providers, resolve root-cause social determinants of health challenges (housing, jobs, transportation, criminal justice), and ensure continuity and cohesion across multiple providers and therapies — supported by the Treus Recovery Intelligence Platform. Delivered to healthcare provider organizations as embedded personnel.

Quantifiable outcome

  • Overdose mortality is declining significantly — but the OUD disease burden remains enormous and substantially under-measured, with an annual economic burden of the opioid crisis exceeding $1 trillion.
  • +1 more outcomes

Companies that use Neurofinity

Customer profile

Segments3 records

Ideal customer profiles2 records

Neurofinity technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability4 records

Feature6 records

Neurofinity partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered flagship, core and minor.

  • Morse ClinicsflagshipStrategic or Co-development PartnerMorse Clinics serves as a primary operating and launch partner for Neurofinity in North Carolina, representing the first deployment of the Neurofinity care model in a live clinical environment. This is a flagship partnership for market validation and model refinement.
  • University of VirginiacoreStrategic or Co-development PartnerUniversity of Virginia operates as a health system partner, integrating the Neurofinity model within its existing care delivery infrastructure as part of a strategic co-development relationship focused on evidence-based OUD care transformation.
  • GenieMDcoreTechnology or IntegrationGenieMD provides OUD care technology platform capabilities as part of Neurofinity's broader technology ecosystem, contributing to the technology infrastructure supporting the Treus platform's care coordination and clinical enablement functions.
  • Videra HealthcoreTechnology or IntegrationVidera Health provides AI behavioral health platform technology integrated into Neurofinity's ecosystem, supporting the AI-assisted measurement and monitoring capabilities of the Treus Recovery Intelligence Platform.
  • Upside HousingcoreStrategic or Co-development PartnerUpside Housing provides housing support services addressing social determinants of health for Neurofinity patients, integrated into the Super Navigator workflow to resolve housing instability — a key driver of relapse and barrier to recovery.
  • Promise Resource NetworkcoreStrategic or Co-development PartnerPromise Resource Network provides peer staffing, training, and oversight services as part of Neurofinity's clinical and peer support ecosystem, contributing to the APRP credentialing and training program and ensuring quality peer recovery support delivery.
  • McGuireWoods ConsultingminorImplementation/ SI/ Consulting PartnerMcGuireWoods Consulting provides government relations and advocacy consulting to Neurofinity, supporting policy engagement and regulatory navigation related to OUD care reimbursement, funding, and policy reform.
  • Tripp|Hollander AdvisorsminorImplementation/ SI/ Consulting PartnerTripp|Hollander Advisors provides government relations and advocacy consulting services to Neurofinity, supporting efforts to advance supportive policy and reimbursement frameworks for OUD care innovation.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Neurofinity competitors and assessment

Company assessment

Others

  • Videra Health: AI behavioral health platform partner already integrated into Neurofinity's ecosystem. Comparable as an enabling technology provider supporting AI-assisted measurement and monitoring.

Direct peers

  • Eleanor Health: Outpatient addiction and mental health provider combining medication-assisted treatment, therapy, and peer recovery support with value-based payer contracts. Comparable integrated OUD/SUD care model with peer-led support.
  • Quit Genius (legacy entity): Predecessor identity of Pelago; historically focused on digital addiction treatment. Listed for completeness as a directly overlapping digital SUD/OUD platform.
  • Boulder Care: Telehealth-based provider of medication-assisted treatment and peer recovery support for opioid use disorder. Comparable as a digitally delivered, peer-supported OUD care model targeting payer partnerships and outcomes-based contracts.
  • Lionrock Recovery: Telehealth provider of substance use disorder treatment including opioid use disorder, delivered via group and individual counseling. Comparable digital OUD/SUD care delivery model.
  • Pelago (formerly Quit Genius): Digital substance use disorder treatment platform serving payers, health systems, and employers with virtual care for tobacco, alcohol, and opioid use disorders. Directly comparable as a B2B-embedded digital SUD/OUD platform pursuing value-based contracts.
  • Workit Health: Virtual substance use disorder care provider offering medication-assisted treatment and counseling for opioid and alcohol use disorders, with B2B partnerships to health plans and providers. Closely aligned on digital OUD treatment and value-based reimbursement.
  • Ophelia: Telehealth platform providing medication-assisted treatment for opioid use disorder, working with health plans and Medicaid on value-based arrangements. Highly comparable on OUD focus, virtual delivery, and payer-aligned reimbursement.

Emerging players

  • Charlie Health: Virtual intensive outpatient and mental health platform for adolescents and adults. Adjacent behavioral health virtual care with growing SUD focus; comparable on platform-enabled, longitudinal virtual care delivery.

Broad incumbents

  • Lyra Health: Large employer-focused mental health platform expanding into substance use care. Comparable as a broader digital behavioral health incumbent serving enterprises and payers.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Neurofinity financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Neurofinity leadership team

Management profile

Number of profiles

Profiles5 records

Neurofinity funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Neurofinity M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neurofinity

What does Neurofinity do?

Neurofinity delivers a personalized, technology-enabled end-to-end OUD care model combining the AI-assisted Treus Recovery Intelligence Platform with Amplified Peer Recovery Professionals (APRPs) and Super Navigators. The platform provides longitudinal measurement, adaptive care planning, and coordinated workflows across hospitals, residential treatment centers, clinics, sober living, home, and community recovery settings. Provider partners receive qualified personnel, elevated training/credentialing, and the Treus technology infrastructure to deliver continuous, whole-person recovery support.

Is Neurofinity a public or private company?

Neurofinity is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Neurofinity founded?

Neurofinity was founded in 2025. It employs 1 to 10 people.

Where is Neurofinity based?

Neurofinity is headquartered in Sedona, United States, in the North America region.

How does Neurofinity make money?

One revenue line is on record: value-Based Reimbursement.

Who are Neurofinity's main competitors?

Videra Health is listed as an others. Direct peers are Eleanor Health, Quit Genius (legacy entity), Boulder Care, Lionrock Recovery, Pelago (formerly Quit Genius), Workit Health and Ophelia. Charlie Health is listed as an emerging player. Lyra Health is listed as a broad incumbent.

Does Neurofinity have an API?

No public API is recorded for Neurofinity.

What industry is Neurofinity in?

Neurofinity's product category is Behavioral Health Technology / Addiction Recovery Platform. Its primary akta.pro industry code is HLALABAK, Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms, with a secondary code of HLALABAG, Post-Acute & Transitional Care Virtual Platforms (SNF/home health coordination). Its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales